Literature DB >> 31753923

Comparing the two leading erythroid lines BEL-A and HUDEP-2.

Deborah E Daniels1,2, Damien J Downes3, Ivan Ferrer-Vicens1, Daniel C J Ferguson1, Belinda K Singleton2,4, Marieangela C Wilson1, Kongtana Trakarnsanga5, Ryo Kurita6, Yukio Nakamura7, David J Anstee2,4, Jan Frayne8,2.   

Abstract

Mesh：

Year:  2019        PMID： 31753923      PMCID： PMC7395286          DOI： 10.3324/haematol.2019.229211

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Generation of red blood cells from human induced pluripotent stem cells.

Authors:  Jessica Dias; Marina Gumenyuk; HyunJun Kang; Maxim Vodyanik; Junying Yu; James A Thomson; Igor I Slukvin
Journal:  Stem Cells Dev       Date:  2011-05-11       Impact factor: 3.272

2.  Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.

Authors:  Chiara Antoniani; Vasco Meneghini; Annalisa Lattanzi; Tristan Felix; Oriana Romano; Elisa Magrin; Leslie Weber; Giulia Pavani; Sara El Hoss; Ryo Kurita; Yukio Nakamura; Thomas J Cradick; Ante S Lundberg; Matthew Porteus; Mario Amendola; Wassim El Nemer; Marina Cavazzana; Fulvio Mavilio; Annarita Miccio
Journal:  Blood       Date:  2018-03-08       Impact factor: 22.113

3.  Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo.

Authors:  Jingping Hu; Jing Liu; Fumin Xue; Gregory Halverson; Marion Reid; Anqi Guo; Lixiang Chen; Azra Raza; Naomi Galili; Julie Jaffray; Joseph Lane; Joel Anne Chasis; Naomi Taylor; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

4.  BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.

Authors:  Matthew C Canver; Elenoe C Smith; Falak Sher; Luca Pinello; Neville E Sanjana; Ophir Shalem; Diane D Chen; Patrick G Schupp; Divya S Vinjamur; Sara P Garcia; Sidinh Luc; Ryo Kurita; Yukio Nakamura; Yuko Fujiwara; Takahiro Maeda; Guo-Cheng Yuan; Feng Zhang; Stuart H Orkin; Daniel E Bauer
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

5.  An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells.

Authors:  Kongtana Trakarnsanga; Rebecca E Griffiths; Marieangela C Wilson; Allison Blair; Timothy J Satchwell; Marjolein Meinders; Nicola Cogan; Sabine Kupzig; Ryo Kurita; Yukio Nakamura; Ashley M Toye; David J Anstee; Jan Frayne
Journal:  Nat Commun       Date:  2017-03-14       Impact factor: 14.919

6.  Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing.

Authors:  Joseph Hawksworth; Timothy J Satchwell; Marjolein Meinders; Deborah E Daniels; Fiona Regan; Nicole M Thornton; Marieangela C Wilson; Johannes Gg Dobbe; Geert J Streekstra; Kongtana Trakarnsanga; Kate J Heesom; David J Anstee; Jan Frayne; Ashley M Toye
Journal:  EMBO Mol Med       Date:  2018-06       Impact factor: 12.137

7.  Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies.

Authors:  Constantinos C Loucari; Petros Patsali; Thamar B van Dijk; Coralea Stephanou; Panayiota Papasavva; Maria Zanti; Ryo Kurita; Yukio Nakamura; Soteroulla Christou; Maria Sitarou; Sjaak Philipsen; Carsten W Lederer; Marina Kleanthous
Journal:  Hum Gene Ther Methods       Date:  2018-02       Impact factor: 2.396

8.  Robust CRISPR/Cas9 Genome Editing of the HUDEP-2 Erythroid Precursor Line Using Plasmids and Single-Stranded Oligonucleotide Donors.

Authors:  Gemma Moir-Meyer; Pak Leng Cheong; Aude-Anais Olijnik; Jill Brown; Samantha Knight; Andrew King; Ryo Kurita; Yukio Nakamura; Richard J Gibbons; Douglas R Higgs; Veronica J Buckle; Christian Babbs
Journal:  Methods Protoc       Date:  2018-07-30

9.  Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.

Authors:  Ryo Kurita; Noriko Suda; Kazuhiro Sudo; Kenichi Miharada; Takashi Hiroyama; Hiroyuki Miyoshi; Kenzaburo Tani; Yukio Nakamura
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS.

Authors:  Kongtana Trakarnsanga; Marieangela C Wilson; Rebecca E Griffiths; Ashley M Toye; Lee Carpenter; Kate J Heesom; Steve F Parsons; David J Anstee; Jan Frayne
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240
View more
  14 in total

Review 1.  Uncovering a Cryptic Site of Malaria Pathogenesis: Models to Study Interactions Between Plasmodium and the Bone Marrow.

Authors:  Tamar P Feldman; Elizabeth S Egan
Journal:  Front Cell Infect Microbiol       Date:  2022-06-02       Impact factor: 6.073

Review 2.  'Enhancing' red cell fate through epigenetic mechanisms.

Authors:  Marlies P Rossmann; Leonard I Zon
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.284

3.  Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient.

Authors:  Kongtana Trakarnsanga; Chartsiam Tipgomut; Chanatip Metheetrairut; Methichit Wattanapanitch; Archrob Khuhapinant; Saiphon Poldee; Ryo Kurita; Yukio Nakamura; Chatchawan Srisawat; Jan Frayne
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

4.  In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2.

Authors:  Magnus A G Hoffmann; Collin Kieffer; Pamela J Bjorkman
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-10       Impact factor: 6.698

5.  Latest culture techniques: cracking the secrets of bone marrow to mass-produce erythrocytes and platelets ex vivo.

Authors:  Christian A Di Buduo; Alicia Aguilar; Paolo M Soprano; Alberto Bocconi; Carolina P Miguel; Giovanna Mantica; Alessandra Balduini
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

6.  BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.

Authors:  Senquan Liu; Mengyao Wu; Moira Lancelot; Jiusheng Deng; Yongxing Gao; John D Roback; Tong Chen; Linzhao Cheng
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

7.  Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase.

Authors:  Prajwal C Boddu; Abhishek K Gupta; Jung-Sik Kim; Karla M Neugebauer; Todd Waldman; Manoj M Pillai
Journal:  Commun Biol       Date:  2021-10-13

8.  Characterization and evolutionary origin of novel C<sub>2</sub>H<sub>2</sub> zinc finger protein (ZNF648) required for both erythroid and megakaryocyte differentiation in humans.

Authors:  Daniel C J Ferguson; Juraidah Haji Mokim; Marjolein Meinders; Edmund R R Moody; Tom A Williams; Sarah Cooke; Kongtana Trakarnsanga; Deborah E Daniels; Ivan Ferrer-Vicens; Deborah Shoemark; Chartsiam Tipgomut; Katherine A Macinnes; Marieangela C Wilson; Belinda K Singleton; Jan Frayne
Journal:  Haematologica       Date:  2021-11-01       Impact factor: 9.941

9.  Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells.

Authors:  Abhirup Bagchi; Aneesha Nath; Vasanth Thamodaran; Smitha Ijee; Dhavapriya Palani; Vignesh Rajendiran; Vigneshwaran Venkatesan; Phaneendra Datari; Aswin Anand Pai; Nancy Beryl Janet; Poonkuzhali Balasubramanian; Yukio Nakamura; Alok Srivastava; Kumarasamypet Murugesan Mohankumar; Saravanabhavan Thangavel; Shaji R Velayudhan
Journal:  Cells       Date:  2021-03-01       Impact factor: 6.600

10.  Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells.

Authors:  Panayiota L Papasavva; Nikoletta Y Papaioannou; Petros Patsali; Ryo Kurita; Yukio Nakamura; Maria Sitarou; Soteroulla Christou; Marina Kleanthous; Carsten W Lederer
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.